Trial · NCT03993132
Results by group28
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 28
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Incidence Rate of Expanded Major Adverse Cardiovascular Event (MACE) Composite Outcome - OT Analysis | Empagliflozin - PS Balanced Cohort | 36.1 | Events per 1000 person-years | ||
| Incidence Rate of Expanded Major Adverse Cardiovascular Event (MACE) Composite Outcome - OT Analysis | Liraglutide - PS Balanced Cohort | 35.9 | Events per 1000 person-years | ||
| Incidence Rate of Expanded Major Adverse Cardiovascular Event (MACE) Composite Outcome - ITT Analysis | Empagliflozin - PS Balanced Cohort | 39.9 | Events per 1000 person-years | ||
| Incidence Rate of Expanded Major Adverse Cardiovascular Event (MACE) Composite Outcome - ITT Analysis | Liraglutide - PS Balanced Cohort | 37.3 | Events per 1000 person-years | ||
| Incidence Rate of Heart Failure (HF) Hospitalization or All-cause Death - OT Analysis | Empagliflozin - PS Balanced Cohort | 21.1 | Events per 1000 person-years | ||
| Incidence Rate of Heart Failure (HF) Hospitalization or All-cause Death - OT Analysis | Liraglutide - PS Balanced Cohort | 22.2 | Events per 1000 person-years | ||
| Incidence Rate of Heart Failure (HF) Hospitalization or All-cause Death - ITT Analysis | Empagliflozin - PS Balanced Cohort | 25.1 | Events per 1000 person-years | ||
| Incidence Rate of Heart Failure (HF) Hospitalization or All-cause Death - ITT Analysis | Liraglutide - PS Balanced Cohort | 24.3 | Events per 1000 person-years | ||
| Incidence Rate of First Hospitalized Heart Failure (HHF) or Initiation of Community Prescription Drug Therapy With Loop Diuretics - OT Analysis | Empagliflozin - PS Balanced Cohort | 12.9 | Events per 1000 person-years | ||
| Incidence Rate of First Hospitalized Heart Failure (HHF) or Initiation of Community Prescription Drug Therapy With Loop Diuretics - OT Analysis | Liraglutide - PS Balanced Cohort | 18.0 | Events per 1000 person-years | ||
| Incidence Rate of First Hospitalized Heart Failure (HHF) or Initiation of Community Prescription Drug Therapy With Loop Diuretics - ITT Analysis | Empagliflozin - PS Balanced Cohort | 17.7 | Events per 1000 person-years | ||
| Incidence Rate of First Hospitalized Heart Failure (HHF) or Initiation of Community Prescription Drug Therapy With Loop Diuretics - ITT Analysis | Liraglutide - PS Balanced Cohort | 21.4 | Events per 1000 person-years | ||
| Incidence Rate of All-cause Hospitalization or Death - OT Analysis | Empagliflozin - PS Balanced Cohort | 193.5 | Events per 1000 patient years | ||
| Incidence Rate of All-cause Hospitalization or Death - OT Analysis | Liraglutide - PS Balanced Cohort | 212.1 | Events per 1000 patient years | ||
| Incidence Rate of All-cause Hospitalization or Death - ITT Analysis | Empagliflozin - PS Balanced Cohort | 175.2 | Events per 1000 patient years | ||
| Incidence Rate of All-cause Hospitalization or Death - ITT Analysis | Liraglutide - PS Balanced Cohort | 187.0 | Events per 1000 patient years | ||
| Incidence Rate of All Cause Hospitalization - OT Analysis | Empagliflozin - PS Balanced Cohort | 190.2 | Events per 1000 patient years | ||
| Incidence Rate of All Cause Hospitalization - OT Analysis | Liraglutide - PS Balanced Cohort | 208.0 | Events per 1000 patient years | ||
| Incidence Rate of All Cause Hospitalization - ITT Analysis | Empagliflozin - PS Balanced Cohort | 171.6 | Events per 1000 patient years | ||
| Incidence Rate of All Cause Hospitalization - ITT Analysis | Liraglutide - PS Balanced Cohort | 183.7 | Events per 1000 patient years |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03993132/results